Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4 CAD | +11.11% | +1.27% | -17.53% |
04-26 | BioNxt Solutions Inc. Announces ODF Cladribine Update | CI |
04-26 | BioNxt Solutions Inc. announced that it expects to receive CAD 1.62 million in funding | CI |
Sales 2022 | 0.3 0.41 | Sales 2023 | 0.37 0.51 | Capitalization | 52.06M 71.17M |
---|---|---|---|---|---|
Net income 2022 | -12M -16.4M | Net income 2023 | -7M -9.57M | EV / Sales 2022 | 195,159,524 x |
Net Debt 2022 | 4.23M 5.79M | Net Debt 2023 | 4.53M 6.19M | EV / Sales 2023 | 152,035,600 x |
P/E ratio 2022 |
-3.99
x | P/E ratio 2023 |
-6.24
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 93.75% |
1 day | +11.11% | ||
1 week | +1.27% | ||
Current month | -14.89% | ||
1 month | -20.00% | ||
3 months | -40.30% | ||
6 months | +60.00% | ||
Current year | -17.53% |
Managers | Title | Age | Since |
---|---|---|---|
Hugh Rogers
CEO | Chief Executive Officer | 44 | 17-12-11 |
P. Meagher
DFI | Director of Finance/CFO | 39 | 21-11-18 |
Wolfgang Probst
BRD | Director/Board Member | 43 | 18-12-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
P. Meagher
DFI | Director of Finance/CFO | 39 | 21-11-18 |
Hugh Rogers
CEO | Chief Executive Officer | 44 | 17-12-11 |
Raimar Löbenberg
BRD | Director/Board Member | 58 | 18-12-09 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.4 | +11.11% | 12,500 |
24-04-23 | 0.36 | 0.00% | 10,500 |
24-04-22 | 0.36 | -8.86% | 6,000 |
Delayed Quote Canadian Securities Exchange, April 26, 2024 at 11:14 am
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.53% | 32M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- BNXT Stock